Last updated on September 2018

Efficacy and Safety of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU)

Brief description of study

The purpose this study is to evaluate the efficacy, safety, and pharmacokinetics of GDC-0853 compared with placebo in participants with Chronic Spontaneous Urticaria (CSU) refractory to anti-histamines.

Clinical Study Identifier: NCT03137069

Contact Investigators or Research Sites near you

Start Over

Reference study Id Number: GS39684 ...

Integrated Research of Inland
Upland, CA United States
  Connect »